Pre Diagnostics is an innovative Norwegian biotech company that seeks to create value for patients, partners, and investors by developing pioneering and patient-friendly, biomarkers for early detection of diseases. The company’s proprietary concept is built upon the scientific premise that a disease evokes systemic responses in macrophages unique to that disease which can be accurately measured in the blood samples of patients.

Pre Diagnostics aims to be a leader in the development of robust biomarkers for neurodegenerative disorders that can be applied for clinical research and diagnostics.

Feel free to explore further information regarding opportunities for partnerships